DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)
MANUFACTURER: Intercept Pharma Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Ocaliva (obeticholic acid) is a drug used to improve liver function and reduce symptoms in adults with primary biliary cholangitis (PBC), a chronic liver disease that damages the bile ducts. It works by activating the farnesoid X receptor (FXR) to regulate the production of bile acids in the liver.